Literature DB >> 49303

Interaction of hepatitis B surface antigen (Australia antigen) with membrane vesicles of Pseudomonas aeruginosa.

L K Weng, M E Bayer, W T London.   

Abstract

A lysogenic strain of Pseudomonas aeruginosa was cultured from the dialysis fluid of a patient on chronic hemodialysis treatment whose blood contained hepatitis B surface antigen (HB8Ag). When this bacterium was incubated for 4 to 7 days with serum containing HB8Ag or with purified HB8Ag, a loss of the HB8Ag-specific immunological reactivity was observed. Bacteriophages can be induced from the isolated P. aeruginosa with mitomycin C; the phages, after purification on CsCl gradients, also lyse P. aeruginosa strain 25102 (ATCC). Subsequent to gradient centrifugation of the lysate, a fraction was found with a density around 1.40 g/ml that inactivated HB8Ag after a 4-h incubation at 37 C as determined by counterelectrophoresis and hemagglutination inhibition. The activity was not found in appreciable amounts in other gradient fractions. The electron microscope shows that the active fraction contains envelope vesicles of 45 to 60 nm in diameter. In spite of their loss in HB8Ag activity, the HB8Ag particles (22nm) appeared morphologically intact. These findings suggest that an enzyme(s) is present in the vesicle fraction which inactivates antigenic determinants on HB8Ag particles. Thus, the presence of these bacteria in environments such as feces, dialysis tanks, and contaminated drinking water may prevent the detection of HB8Ag.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49303      PMCID: PMC415264          DOI: 10.1128/iai.12.1.180-186.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer.

Authors:  S C Schimpff; W H Greene; V M Young; P H Wiernik
Journal:  Eur J Cancer       Date:  1973-06       Impact factor: 9.162

2.  Characterization of a membrane-associated ATPase from Pseudomonas aeruginosa.

Authors:  W L Thacker; R G Eagon
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

3.  Infections in heroin addicts.

Authors:  R J Lewis
Journal:  JAMA       Date:  1973-02-26       Impact factor: 56.272

4.  Loss of immunologic reactivities of Australia antigen after incubation with bacteria.

Authors:  S Mazzur; J Corbett; B S Blumberg
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

Review 5.  Ultrastructure of bacteriophage and bacteriocins.

Authors:  D E Bradley
Journal:  Bacteriol Rev       Date:  1967-12

6.  Spinal Pseudomonas chondro-osteomyelitis in heroin users.

Authors:  R Lewis; S Gorbach; P Altner
Journal:  N Engl J Med       Date:  1972-06-15       Impact factor: 91.245

7.  Pseudomonas aeruginosa bacteremia in patients with neoplastic disease.

Authors:  L S Fishman; D Armstrong
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

8.  Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources.

Authors:  M R Moody; V M Young; D M Kenton; G D Vermeulen
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

9.  Hepatitis B antigen: antigenic sites related to human serum proteins revealed by affinity chromatography.

Authors:  A R Neurath; A M Prince; A Lippin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

10.  Australia antigen (a hepatitis-associated antigen): purification and physical properties.

Authors:  I Millman; L A Loeb; M E Bayer; B S Blumberg
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  3 in total

1.  Glycoproteins of natural origin with an affinity for hepatitis B surface antigen.

Authors:  I Millman; J C McMichael
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Serum iron levels and response to hepatitis B virus.

Authors:  C Felton; E D Lustbader; C Merten; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

3.  Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice.

Authors:  Haruki Komatsu; Ayano Inui; Takeyoshi Murano; Tomoyuki Tsunoda; Tsuyoshi Sogo; Tomoo Fujisawa
Journal:  BMC Res Notes       Date:  2015-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.